Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · National Health Investors (NHI)

NHI Q4 2025 EPS fell to $0.80 from $0.95; normalized FFO rose to $1.22

Mixed Impact 3 of 5 earnings Written later

National Health Investors reported fourth quarter 2025 results and introduced 2026 annual guidance. Diluted earnings per share fell to $0.80 from $0.95 a year earlier, while normalized FFO per diluted share rose to $1.22 from $1.12, and the company projects 2026 normalized FFO per diluted share of $4.94 to $4.99.

Key points

  • Q4 2025 diluted EPS was $0.80 versus $0.95 in Q4 2024; NAREIT FFO per diluted share was $1.22 versus $1.24.
  • Full-year 2025 normalized FFO per diluted share was $4.91 versus $4.44 in 2024; diluted EPS was $3.02 versus $3.13.
  • 2026 guidance: normalized FFO per diluted share of $4.94 to $4.99 and normalized FAD of $248.9 million to $251.4 million.
  • As of December 31, 2025, net debt was $1.2 billion and net debt to adjusted EBITDA was 3.8x.

The filing

CompanyNational Health Investors (NHI)
Form8-K, current report
Filed with the SECFeb 26, 2026, 4:12 PM ET
Accession number0000877860-26-000054

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 26, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.